Atara Biotherapeutics (ATRA) Revenue (2013 - 2026)
Atara Biotherapeutics (ATRA) revenue from Sep 30, 2013 to Mar 31, 2026. The TTM Atara Biotherapeutics (ATRA) revenue is $23M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Atara Biotherapeutics (ATRA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -88.41% |
| 3 Years TTM | -26.16% |
Annual Revenue change of Atara Biotherapeutics (ATRA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $520K | -99.57% |
| 2025 | $121M | -6.34% |
| 2024 | $129M | +1404.55% |
| 2023 | $8.57M | -86.52% |
| 2022 | $64M | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |